APA (7th ed.) Citation

C, B., B, M., MF, B., RS, M., RA, B., W, W., . . . MJ, B. (2017). Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses. Journal of the National Cancer Institute, 109(11), . https://doi.org/10.1093/jnci/djx066

Chicago Style (17th ed.) Citation

C, Bais, et al. "Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses." Journal of the National Cancer Institute 109, no. 11 (2017). https://doi.org/10.1093/jnci/djx066.

MLA (9th ed.) Citation

C, Bais, et al. "Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses." Journal of the National Cancer Institute, vol. 109, no. 11, 2017, https://doi.org/10.1093/jnci/djx066.